We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





Horiba Showcases HELO Global Hematology Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023
Print article
Image: HELO Global Hematology Solution fulfills all the needs of a high throughput automated hematology platform (Photo courtesy of Horiba)
Image: HELO Global Hematology Solution fulfills all the needs of a high throughput automated hematology platform (Photo courtesy of Horiba)

Horiba Medical (Kyoto, Japan) is showcasing its extensive and comprehensive line of hematology, hemostasis, and clinical chemistry solutions, including analyzers, reagents, and consumables, for in vitro diagnostics at Medlab Middle East 2023.

At this year’s Medlab Middle East, Horiba is presenting HELO (HORIBA Evolutive Laboratory Organization), its global hematology solution. With an innovative design solution covering all the needs of a high throughput automated hematology platform, the flexible and efficient HELO is the optimum answer to the constant evolution of laboratories. The HORIBA advanced technologies embedded in the Yumizen H2500/H1500 associated with over 30 years of experience in hematology diagnosis offer the highest analytical performances. Thanks to its data, tube management, blood film, and digitalization management capability, HELO not only addresses all needs but also helps optimize TAT, floor space and reagent storage. HELO comes with Horiba’s accreditation assistance program which has been developed in accordance with ISO-15189 certification.

Horiba is also showcasing the new Yumizen H500 and H550 compact benchtop hematology analyzers with enhanced performance, new features, and increased benefits, alongside the Microsemi CRP LC-767G hematology analyzer that enables simultaneous blood analysis + CRP measurement, along with data management. In addition, Horiba is highlighting the Yumizen G1550/G1500 automated hemostasis analyzer that offers routine and specialized testing in a single analysis system, alongside the Yumizen G400 semi-automated hemostasis analyzer that offers a smart way to test with four independent measuring channels and 20 incubation positions.

Among its clinical chemistry solutions, Horiba is presenting the Pentra C200 clinical chemistry analyzer with fixed cycles that provides a continuous throughput of 90 colorimetric tests/hour, alongside the Pentra C400 clinical chemistry analyzer that features 55 on-board assays, an innovative cassette format, and integrated workstation and validation station. Among its laboratory automation solutions, Horiba is showcasing the Yumizen T6000 automated rack conveyor that is fully compatible with laboratory architecture (spaces, walls, columns) due to wide configurations of panels (linear, work cell, angular, island), alongside the Cube S robotic workstation that manages pre and post-analytical sorting, storing, and tracking of sample tubes in a laboratory.

Related Links:
Horiba Medical

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Unit-Dose Packaging solution
HLX
New
Respiratory Syncytial Virus Test
QuickVue RSV Test
New
Anti-Rubella IgG (Rubella IgG) Test
Rubella IgG AccuBind ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: Last year, Seegene and Werfen has entered into a collaboration on the OneSystem business to develop syndromic qPCR assays (Photo courtesy of Seegene)

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

Seegene (Seoul, South Korea), a leading PCR molecular diagnostics company, and Werfen (Barcelona, Spain), a global diagnostics specialist, have finalized a partnership agreement as part of a technology-sharing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.